No Data
No Data
US Court Rejects Novartis' Appeal to Block Heart Failure Drug's Generic Version
Top Gap Ups and Downs on Wednesday: CRM, NOW, AZN and More
Incyte Gains Amid Takeover Speculation
HSBC Downgrades Novartis to Reduce, Price Target Is $95
Novartis In-Licenses PTCT's Huntington's Disease Drug for $2.9 Billion
PTCT Stock Soars on Licensing Deal With NVS for Huntington's Therapy
No Data
103827296 : Halo Medan hai hai English understand I'm sorry
72627089 : fractional shares
72627089 : would like to chat about fractional shares
(R-long)103834298 : stop all
l0lBElBgG : k